As of 2025-07-17, the Relative Valuation of Finch Therapeutics Group Inc (FNCH) is (16.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.80 USD, the upside of Finch Therapeutics Group Inc based on Relative Valuation is -1004.4%.
The range of the Relative Valuation is (15.72) - (22.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 18.7x | 13.1x |
| Forward P/E multiples | 12.6x - 21.3x | 13.7x |
| Fair Price | (15.72) - (22.72) | (16.28) |
| Upside | -973.4% - -1362.2% | -1004.4% |
| Date | P/E |
| 2025-07-11 | -10.49 |
| 2025-07-10 | -10.49 |
| 2025-07-07 | -10.70 |
| 2025-07-03 | -10.76 |
| 2025-06-26 | -10.86 |
| 2025-06-24 | -10.70 |
| 2025-06-23 | -10.71 |
| 2025-06-20 | -11.07 |
| 2025-06-18 | -11.06 |
| 2025-06-17 | -11.19 |
| 2025-06-16 | -11.19 |
| 2025-06-13 | -11.32 |
| 2025-06-12 | -10.60 |
| 2025-06-11 | -11.28 |
| 2025-06-09 | -11.02 |
| 2025-06-06 | -11.17 |
| 2025-06-04 | -11.15 |
| 2025-06-02 | -11.19 |
| 2025-05-30 | -11.11 |
| 2025-05-29 | -11.22 |
| 2025-05-27 | -11.28 |
| 2025-05-23 | -10.70 |
| 2025-05-22 | -10.70 |
| 2025-05-21 | -11.19 |
| 2025-05-20 | -11.19 |
| 2025-05-19 | -11.10 |
| 2025-05-16 | -10.91 |
| 2025-05-15 | -10.87 |
| 2025-05-14 | -10.74 |
| 2025-05-13 | -10.84 |
| 2025-05-12 | -10.67 |
| 2025-05-08 | -11.11 |
| 2025-05-06 | -10.49 |
| 2025-05-05 | -10.33 |
| 2025-05-02 | -10.49 |
| 2025-05-01 | -10.49 |
| 2025-04-30 | -10.29 |
| 2025-04-29 | -10.12 |
| 2025-04-28 | -10.12 |
| 2025-04-25 | -10.37 |
| 2025-04-24 | -10.17 |
| 2025-04-23 | -10.41 |
| 2025-04-22 | -10.49 |
| 2025-04-21 | -10.66 |
| 2025-04-17 | -10.70 |
| 2025-04-16 | -10.70 |